Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James W. Mccollum currently holds 22,100 shares of LENZ Therapeutics, Inc. (LENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James W. Mccollum has been a net buyer of LENZ stock. They have purchased $740.3K and sold $0 worth of shares.
James W. Mccollum's most recent insider trade was on Jun 15, 2026, when they sold 22,100 shares at $0.00 per share.
James W. Mccollum serves as Executive at LENZ Therapeutics, Inc. (LENZ). They have executed 8 insider transactions totaling $740.3K over their tenure at the company.
James W. Mccollum holds the position of Executive at LENZ Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
James W. Mccollum has shown a buying trading pattern, with $740.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James W. Mccollum was on May 13, 2024, when they purchased $501.0K worth of LENZ shares. This transaction involved 31,332 shares at $15.99 per share.
James W. Mccollum currently owns 22,100 shares of LENZ Therapeutics, Inc. (LENZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James W. Mccollum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James W. Mccollum has 8 Form 4 filings on record as an insider at LENZ Therapeutics, Inc..
Set alerts for James W. Mccollum and 40,000+ other insiders.